SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Spectranetics (SPNC): Any info?
SPNC 38.450.0%Aug 10 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Volsi Mimir who wrote (41)12/31/1999 1:20:00 PM
From: Greg Jung  Read Replies (1) of 60
 
Back in the lower end of recent range, (3.75 - 5): I see
on Yahoo that VP sales & marketing, Americas has doubled his
position on 8-15-99 at $3.75. I sold out (my "nervous cash" account) when the breakout scenario didn't pan out but it may still develop when market focus rotates to medical devices.

Some more tidbits from the Yahoo pages:


Ownership
ú
Insider: 20%
ú
Over the last 6 months:
ú 4 insider buys; 23.0K shares (0.5% of
insider shares)
ú
Institutional: 15% (18% of float)
(28 institutions)
ú
Net Inst. Selling: 1.55M shares (+86.16%)
(prior quarter to latest quarter)

Robertson Stephens issued a Daily Notes Report on December 1, 1999 for Spectranetics Corp..

On December 1, 1999 Robertson Stephens analyst Michael King issued a 3 page Company Report on Spectranetics Corp.
Report highlights: 'An ATTRACTIVE rating was maintained based on expected additional regulatory approvals.
The company reported 3Q99 EPS of ($0.01). The company is
expected to generate earnings growth of 25% over the next
three years.'

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext